These 2 FTSE giants are making the news! Should you buy?

Royston Wild discusses the investment prospects of two London newsmakers.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Medical giant Georgia Healthcare Group (LSE: GHG) edged higher on Monday after the release of bubbly half-year numbers.

The company — a leading provider of healthcare services in Georgia — saw sales leap 56% between January and June, to a record 174.2m Georgian lari (GEL). As a result net profit cantered to GEL45.2m from GEL13.3m a year earlier.

The results led chief executive Nikoloz Gamkrelidze to comment that “we remain well positioned to continue delivering a strong performance throughout 2016 and beyond, from both high levels of organic revenue growth as well as from the benefits of our key strategic priorities and recent acquisitions.”

Georgia Healthcare Group aims to double healthcare revenues by 2018, the healthcare play aiming to eventually control one third of the country’s hospital beds, and to rapidly improve its footprint in the outpatient market by launching ambulatory clinics.

And the Eastern European firm’s acquisition strategy saw it snap up GPC in May to bolster its position in the Georgian healthcare market. The company is one of the largest retail and wholesale pharmacy chains in the country and this makes the FTSE play one of the biggest drugs purchasers in the country.

I reckon Georgia Healthcare Group’s growing presence in a classic defensive segment, not to mention focus on a healthily-expanding overseas marketplace, makes it an exciting stock candidate for growth seekers.

Running aground?

Shares in shipping giant Clarkson (LSE: CKN) leapt 9% higher in Monday business after better-than-expected financials.

Clarkson saw revenues edge to £147.2m during January-June, up from £145.3m a year earlier. However, this couldn’t prevent underlying pre-tax profit from slipping to £21.8m in the period from £23.6m in the same 2015 duration.

Indeed, Clarkson advised that “the global shipping industry is experiencing the most challenging rate environment seen in many years which… has inevitably impacted the group’s performance for the first six months of 2016.”

The shipper’s ClarkSea Index, which assesses the earnings of main vessel types, slumped 30% in the half and accompanied the Baltic Dry Index touching fresh record lows.

And Clarkson warned that it expects conditions to remain difficult in the short term, “reflecting the ongoing supply demand imbalance with the resultant low levels of newbuilding contracts and a prevalence of spot business continuing to limit forward visibility of earnings.”

Clarkson remains in severe danger of prolonged bottom-line woe as ample shipping capacity and insipid demand weighs. And latest export data from China indicates that an upturn in global trade is a long way off — exports slumped 4.4% year-on-year in July on a dollar-denominated basis.

I reckon Clarkson remains a poor ‘contrarian’ share pick, particularly given its forward P/E rating of 34 times, a figure that fails to adequately reflect its mammoth risk profile.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Royston Wild has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

If interest rate cuts are coming, I think these UK growth stocks could soar!

Falling interest could be great news for UK growth stocks, especially those that have been under the cosh recently. Paul…

Read more »

Investing Articles

Are these the best stocks to buy on the FTSE right now?

With the UK stock market on the way to hitting new highs, this Fool is considering which are the best…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »

Investing Articles

Are HSBC shares a FTSE bargain? Here’s what the charts say!

There are plenty of dirt-cheap FTSE 100 banking stocks for investors to choose from today. Our writer Royston Wild believes…

Read more »